Pharmasimple SA
PAR:ALPHS
Cash Flow Statement
Cash Flow Statement
Pharmasimple SA
| Jun-2019 | Jun-2020 | ||
|---|---|---|---|
| Operating Cash Flow | |||
| Net Income |
0
|
1
|
|
| Depreciation & Amortization |
0
|
1
|
|
| Change in Working Capital |
1
|
(1)
|
|
| Cash from Operating Activities |
1
N/A
|
1
-14%
|
|
| Investing Cash Flow | |||
| Capital Expenditures |
(5)
|
6
|
|
| Other Items |
0
|
0
|
|
| Cash from Investing Activities |
(5)
N/A
|
6
N/A
|
|
| Financing Cash Flow | |||
| Net Issuance of Common Stock |
2
|
0
|
|
| Net Issuance of Debt |
(1)
|
0
|
|
| Other |
4
|
(4)
|
|
| Cash from Financing Activities |
5
N/A
|
(6)
N/A
|
|
| Change in Cash | |||
| Net Change in Cash |
1
N/A
|
1
-27%
|
|
| Free Cash Flow | |||
| Free Cash Flow |
(4)
N/A
|
7
N/A
|
|